161 related articles for article (PubMed ID: 3497950)
1. Selective blockade of the antigen-receptor-mediated pathway of T cell activation in patients with impaired primary immune responses.
Meuer SC; Hauer M; Kurz P; Meyer zum Büschenfelde KH; Köhler H
J Clin Invest; 1987 Sep; 80(3):743-9. PubMed ID: 3497950
[TBL] [Abstract][Full Text] [Related]
2. Selective functional deficit in dendritic cell--T cell interaction is a crucial mechanism in chronic hepatitis B virus infection.
Zheng BJ; Zhou J; Qu D; Siu KL; Lam TW; Lo HY; Lee SS; Wen YM
J Viral Hepat; 2004 May; 11(3):217-24. PubMed ID: 15117323
[TBL] [Abstract][Full Text] [Related]
3. Non-responsiveness to hepatitis B vaccination in haemodialysis patients: association with impaired TCR/CD3 antigen receptor expression regulating co-stimulatory processes in antigen presentation and recognition.
Stachowski J; Pollok M; Barth C; Maciejewski J; Baldamus CA
Nephrol Dial Transplant; 1994; 9(2):144-52. PubMed ID: 7910675
[TBL] [Abstract][Full Text] [Related]
4. Expression of receptors for interleukin 2: Role in the commitment of T lymphocytes to proliferate.
Lipkowitz S; Greene WC; Rubin AL; Novogrodsky A; Stenzel KH
J Immunol; 1984 Jan; 132(1):31-7. PubMed ID: 6418801
[TBL] [Abstract][Full Text] [Related]
5. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
[TBL] [Abstract][Full Text] [Related]
6. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
7. Genetic regulation of the immune response to hepatitis B surface antigen (HBsAg). V. T cell proliferative response and cellular interactions.
Milich DR; Louie RE; Chisari FV
J Immunol; 1985 Jun; 134(6):4194-202. PubMed ID: 3921619
[TBL] [Abstract][Full Text] [Related]
8. Defect of interleukin-2 production and T cell proliferation in atopic patients: restoring ability of the CD28-mediated activation pathway.
Romano MF; Turco MC; Stanziola A; Giarrusso PC; Petrella A; Tassone P; van Lier R; Venuta S; Formisano S
Cell Immunol; 1993 May; 148(2):455-63. PubMed ID: 8098674
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination.
Bauer T; Jilg W
Vaccine; 2006 Jan; 24(5):572-7. PubMed ID: 16171909
[TBL] [Abstract][Full Text] [Related]
10. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
11. Determinants of soluble CD23 antigen levels in hemodialysis patients: effect of 1.25 dihydroxyvitamin D3 and recombinant human erythropoietin treatment.
Altun B; Erdem Y; Usalan C; Arici M; Haznedaroglu IC; Yasavul U; Turgan C; Caglar S; Kirazli S
Clin Nephrol; 1999 Oct; 52(4):230-8. PubMed ID: 10543325
[TBL] [Abstract][Full Text] [Related]
12. The effect of host immunity on hepatitis B antigen (HBAg) infection in hemodialysis patiets.
Rashid A; Sengar D; McLeish W; Sutherland M; Harris J; Couture R
Trans Am Soc Artif Intern Organs; 1975; 21():483-7. PubMed ID: 1079982
[No Abstract] [Full Text] [Related]
13. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
[TBL] [Abstract][Full Text] [Related]
14. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
[TBL] [Abstract][Full Text] [Related]
15. Reduced alloreactive T-cell activation after alcohol intake is due to impaired monocyte accessory cell function and correlates with elevated IL-10, IL-13, and decreased IFNgamma levels.
Szabo G; Mandrekar P; Dolganiuc A; Catalano D; Kodys K
Alcohol Clin Exp Res; 2001 Dec; 25(12):1766-72. PubMed ID: 11781510
[TBL] [Abstract][Full Text] [Related]
16. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
17. Natural killer cell alterations correlate with loss of renal function and dialysis duration in uraemic patients.
Vacher-Coponat H; Brunet C; Lyonnet L; Bonnet E; Loundou A; Sampol J; Moal V; Dussol B; Brunet P; Berland Y; Dignat-George F; Paul P
Nephrol Dial Transplant; 2008 Apr; 23(4):1406-14. PubMed ID: 18029366
[TBL] [Abstract][Full Text] [Related]
18. The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation.
Goncalves L; Albarran B; Salmen S; Borges L; Fields H; Montes H; Soyano A; Diaz Y; Berrueta L
Virology; 2004 Aug; 326(1):20-8. PubMed ID: 15262491
[TBL] [Abstract][Full Text] [Related]
19. Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes.
Tsoukas CD; Landgraf B; Bentin J; Valentine M; Lotz M; Vaughan JH; Carson DA
J Immunol; 1985 Sep; 135(3):1719-23. PubMed ID: 3926881
[TBL] [Abstract][Full Text] [Related]
20. Acute effects of dialysis on T lymphocytes in patients with end-stage renal disease.
Chandy KG; Pahl M; Vaziri ND; Gupta S
J Clin Lab Immunol; 1985 Jul; 17(3):119-24. PubMed ID: 3930749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
